FDA: approval of zolgensma was based on manipulated data
The maker of Zolgensma (onasemnogene abeparvovec-xioi) gave manipulated data to the U.S. Food and Drug Administration when it approved the drug, the agency said Tuesday.
Aug 8, 2019
0
2
Archive: 08/08/2019
